BioCentury
ARTICLE | Company News

Argonex, Wyeth-Lederle Vaccines deal

February 7, 2000 8:00 AM UTC

Argonex will isolate, identify and sequence peptides expressed on Chlamydia pneumoniae-infected cells. Wyeth will evaluate the peptides for use in developing vaccines, and Argonex will receive resear...